Application of Decision-Analytic Models to Evaluate Integrated Care Interventions for Cardiometabolic Multimorbidity: A Systematic Review
References
- Goodman RA, Posner SF, Huang ES, et al. Defining and measuring chronic conditions: imperatives for research, policy, program, and practice. Prev Chronic Dis. 2013;10:
E66 . DOI: 10.5888/pcd10.120239 - World Health Organization. Noncommunicable diseases fact sheet. 2021.
https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases . - World Health Organization. Noncommunicable diseases progress monitor. 2022.
- Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. DOI: 10.1016/S0140-6736(20)30925-9
- World Health Organization. World health statistics 2023: monitoring health for the SDGs. 2023.
- Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: The neglected chronic diseases of adults. Lancet. 2003;362(9387):903–908. DOI: 10.1016/S0140-6736(03)14335-8
- Popkin BM. The nutrition transition: an overview of world patterns of change. Nutr Rev. 2004;62:S140–S143. DOI: 10.1111/j.1753-4887.2004.tb00084.x
- Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70:3–21. DOI: 10.1111/j.1753-4887.2011.00456.x
- Aiden H. Multimorbidity understanding the challenge. A report for the Richmond group of charities.
- Mercer S, Furler J, Moffat K, et al. Multimorbidity: technical series on safer primary care. World Health Organization; 2016.
- Academy of Science of South Africa. Improving the prevention and management of multimorbidity in sub-Saharan Africa.
- Cheng X, Ouyang F, Ma T, et al. Association of Healthy Lifestyle and Life Expectancy in Patients With Cardiometabolic Multimorbidity: A Prospective Cohort Study of UK Biobank. Frontiers in Cardiovascular Medicine; 9. Epub ahead of print 2022. DOI: 10.3389/fcvm.2022.830319
- Doessing A, Burau V. Care coordination of multimorbidity: a scoping study. Journal of Comorbidity. 2015;5:15–28. DOI: 10.15256/joc.2015.5.39
- Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43. DOI: 10.1016/S0140-6736(12)60240-2
- Brilleman SL, Purdy S, Salisbury C, et al. Implications of comorbidity for primary care costs in the UK: a retrospective observational study. Br J Gen Pract. 2013;63:e274–e282. DOI: 10.3399/bjgp13X665242
- Lee JT, Hamid F, Pati S, et al. Impact of noncommunicable disease multimorbidity on healthcare utilisation and out-of-pocket expenditures in middle-income countries: cross sectional analysis. PLoS One. 2015;10:
e0127199 . DOI: 10.1371/journal.pone.0127199 - Figueroa JF, Papanicolas I, Riley K, et al. International comparison of health spending and utilization among people with complex multimorbidity. Health Serv Res. 2021;56(S3):1317–1334. DOI: 10.1111/1475-6773.13708
- Buddeke J, Bots ML, Van Dis I, et al. Comorbidity in patients with cardiovascular disease in primary care: a cohort study with routine healthcare data. Br J Gen Pract. 2019;69:e398–e406. DOI: 10.3399/bjgp19X702725
- Chowdhury SR, Das DC, Sunna TC, et al. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. Eclinicalmedicine. 57. DOI: 10.1016/j.eclinm.2023.101860
- Nguyen H, Manolova G, Daskalopoulou C, et al. Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies. Journal of Comorbidity. 2019;9. DOI: 10.1177/2235042X19870934
- Asogwa OA, Boateng D, Marzà-Florensa A, et al. Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open. 2022;12:
e049133 . DOI: 10.1136/bmjopen-2021-049133 - Kaluvu L, Asogwa OA, Marzà-Florensa A, et al. Multimorbidity of communicable and non-communicable diseases in low-and middle-income countries: A systematic review. Journal of Multimorbidity and Comorbidity. 2022;12:
26335565221112590 . DOI: 10.1177/26335565221112593 - Koné Pefoyo AJ, Bronskill SE, Gruneir A, et al. The increasing burden and complexity of multimorbidity. BMC Public Health. 2015;15:1–11. DOI: 10.1186/s12889-015-1733-2
- World Health Organization. Noncommunicable diseases country profiles; 2018.
- Bähler C, Huber CA, Brüngger B, et al. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study. BMC Health Serv Res. 2015;15:1–12. DOI: 10.1186/s12913-015-0698-2
- Palladino R, Tayu Lee J, Ashworth M, et al. Associations between multimorbidity, healthcare utilisation and health status: evidence from 16 European countries. Age Ageing. 2016;45:431–435. DOI: 10.1093/ageing/afw044
- Baxter S, Johnson M, Chambers D, et al. The effects of integrated care: a systematic review of UK and international evidence. BMC Health Serv Res. 2018;18:1–13. DOI: 10.1186/s12913-018-3161-3
- Mounier-Jack S, Mayhew SH, Mays N. Integrated care: learning between high-income, and low-and middle-income country health systems. Health Policy Plan. 2017;32:iv6–iv12. DOI: 10.1093/heapol/czx039
- Hort K, Gilbert K, Basnayaka P, et al. Strategies to strengthen referral from primary care to secondary care in low-and middle-income countries.
- Briggs CJ, Garner P. Strategies for integrating primary health services in middle-and low-income countries at the point of delivery. Cochrane Database Syst Rev.
- Hopman P, de Bruin SR, Forjaz MJ, et al. Effectiveness of comprehensive care programs for patients with multiple chronic conditions or frailty: A systematic literature review. Health Policy. 2016;120:818–832. DOI: 10.1016/j.healthpol.2016.04.002
- McCarthy D, Ryan J, Klein S. Models of Care for High-Need, High-Cost Patients: An Evidence Synthesis. Issue Brief. 2015;31:1–19.
- Palmer K, Marengoni A, Forjaz MJ, et al. Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). Health Policy. 2018;122:4–11. DOI: 10.1016/j.healthpol.2017.09.006
- Valentijn PP, Pereira FA, Ruospo M, et al. Person-Centered Integrated Care for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin J Am Soc Nephrol. 2018;13:375–386. DOI: 10.2215/CJN.09960917
- Otieno P, Agyemang C, Wao H, et al. Effectiveness of integrated chronic care models for cardiometabolic multimorbidity in sub-Saharan Africa: a systematic review and meta-analysis. BMJ Open. 2023;13:
e073652 . DOI: 10.1136/bmjopen-2023-073652 - Taylor AH, Taylor RS, Ingram WM, et al. Adding web-based behavioural support to exercise referral schemes for inactive adults with chronic health conditions: the e-coachER RCT. Health Technol Assess. 2020;24:
1 . DOI: 10.3310/hta24630 - Soto J. Health Economic Evaluations Using Decision Analytic Modeling: Principles and Practices—Utilization of a Checklist to Their Development and Appraisal. Int J Technol Assess Health Care. 2002;18:94–111.
- Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. OUP Oxford; 2006.
https://play.google.com/store/books/details?id=NuYRBAAAQBAJ . - Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006;15:1295–1310. DOI: 10.1002/hec.1148
- Cooper K, Brailsford SC, Davies R. Choice of modelling technique for evaluating health care interventions. J Oper Res Soc. 2007;58:168–176. DOI: 10.1057/palgrave.jors.2602230
- Sando D, Kintu A, Okello S, et al. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda. J Int AIDS Soc. 2020;23:
e25507 . DOI: 10.1002/jia2.25507 - Haji Ali Afzali H, Gray J, Beilby J, et al. A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in Australia. Appl Health Econ Health Policy. 2013;11:661–670. DOI: 10.1007/s40258-013-0062-9
- Hirsch JD, Bounthavong M, Arjmand A, et al. Estimated cost-effectiveness, cost benefit, and risk reduction associated with an endocrinologist-pharmacist diabetes intense medical management “tune-up” clinic. Journal of Managed Care & Specialty Pharmacy. 2017;23:318–326. DOI: 10.18553/jmcp.2017.23.3.318
- Wambiya EOA, Oguta J, Akparibo R, et al. A systematic review of model-based economic evaluations of the health and economic impacts of integrated care on prevention and management of cardiometabolic multimorbidity. PROSPERO CRD42023407278; 2023.
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023407278 (accessed May 2023). - Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341. DOI: 10.1016/j.ijsu.2010.02.007
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:
105906 . DOI: 10.1016/j.ijsu.2021.105906 - Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press; 2015.
https://play.google.com/store/books/details?id=yzZSCwAAQBAJ - Turner HC, Archer RA, Downey LE, et al. An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations. Front Public Health. 2021;9:
722927 . DOI: 10.3389/fpubh.2021.722927 - Aga F, Dunbar SB, Kebede T, et al. The role of concordant and discordant comorbidities on performance of self-care behaviors in adults with type 2 diabetes: a systematic review. Diabetes Metab Syndr Obes. 2019;333–356. DOI: 10.2147/DMSO.S186758
- Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725–731. DOI: 10.2337/diacare.29.03.06.dc05-2078
- Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1.
- Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288:1909–1914. DOI: 10.1001/jama.288.15.1909
- Singer SJ, Burgers J, Friedberg M, et al. Defining and measuring integrated patient care: promoting the next frontier in health care delivery. Med Care Res Rev. 2011;68:112–127. DOI: 10.1177/1077558710371485
- Philips Z, Bojke L, Sculpher M, et al. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics. 2006;24:355–371. DOI: 10.2165/00019053-200624040-00006
- Dukpa W, Teerawattananon Y, Rattanavipapong W, et al. Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan. Health Policy & Planning. 2015;30:1032–1043. DOI: 10.1093/heapol/czu106
- Mousa R, Hammad E. Cost-effectiveness of pharmacist-led care versus usual care in type 2 diabetic Jordanians: a Markov modeling of cardiovascular diseases prevention. Expert Rev Pharmacoecon Outcomes Res. 2021;21(5):1069–1079. DOI: 10.1080/14737167.2021.1838900
- Kasaie P, Weir B, Schnure M, et al. Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective. J Int AIDS Soc. 2020;23 Suppl 1:
e25499 . DOI: 10.1002/jia2.25499 - Penaloza-Ramos MC, Jowett S, Mant J, et al. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR). Eur J Prev Cardiol. 2016;23(9):902–912. DOI: 10.1177/2047487315618784
- Kim W, Lee SA, Chun SY. A cost-effectiveness analysis of the Chronic Disease Management Program in patients with hypertension in Korea. Int J Qual Health Care. 2021;33:
30 . DOI: 10.1093/intqhc/mzab073 - Schultz BG, Tilton J, Jun J, et al. Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management. Value Health. 2020;24:522–529. DOI: 10.1016/j.jval.2020.10.008
- Schouten LM, Niessen LW, van de Pas JW, et al. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes. Med Care. 2010;48:884–891. DOI: 10.1097/MLR.0b013e3181eb318f
- Hobbs FDR, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005;9:iii–iv, ix–x:1–74. DOI: 10.3310/hta9400
- Mason JM, Freemantle N, Gibson JM, et al. Specialist nurse–led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trial. Diabetes Care. 2005;28:40–46. DOI: 10.2337/diacare.28.1.40
- Schaufler TM, Wolff M. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in germany. Appl Health Econ Health Policy. 2010;8(3):191–202. DOI: 10.2165/11532880-000000000-00000
- Howard K, White S, Salkeld G, et al. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: A modeled analysis. Value Health. 2010;13(2):196–208. DOI: 10.1111/j.1524-4733.2009.00668.x
- Schuetz CA, Alperin P, Guda S, et al. A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis. PLoS One. 8(7):(no pagination). Epub ahead of print 2013. DOI: 10.1371/journal.pone.0066454
- Wang P-E, Wang T-T, Chiu Y-H, et al. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions? J Med Screen. 2006;13 Suppl 1:S54–S58. DOI: 10.1177/0969141306013001S13
- Afzali HHA, Karnon J, Gray J, et al. A model-based evaluation of collaborative care in management of patients with type 2 diabetes in Australia: an initial report. Aust Health Rev. 2012;36:258–263. DOI: 10.1071/AH11084
- Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. 2004;47:1747–1759. DOI: 10.1007/s00125-004-1527-z
- Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci. 2001;101:671–679. DOI: 10.1042/cs1010671
- Adler AI. UKPDS—modelling of cardiovascular risk assessment and lifetime simulation of outcomes. Diabet Med. 2008;25:41–46. DOI: 10.1111/j.1464-5491.2008.02498.x
- Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003;26:3093–3101. DOI: 10.2337/diacare.26.11.3093
- Stover J, Brown T, Puckett R, et al. Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators. AIDS. 2017;31:S5–S11. DOI: 10.1097/QAD.0000000000001322
- Kariuki JK, Stuart-Shor EM, Leveille SG, et al. Validation of the nonlaboratory-based Framingham cardiovascular disease risk assessment algorithm in the Atherosclerosis Risk in Communities dataset. J Cardiovasc Med. 2017;18:936–945. DOI: 10.2459/JCM.0000000000000583
- Wroe EB, Mailosi B, Price N, et al. Economic evaluation of integrated services for non-communicable diseases and HIV: costs and client outcomes in rural Malawi. BMJ Open. 2022;12:
e063701 . DOI: 10.1136/bmjopen-2022-063701 - Szafraniec-Burylo SI, Sliwczynski A, Tyszko P, et al. The implementation of integrated care for cardiovascular diseases in Poland. Int J Integr Care. 2016;16:1–2. DOI: 10.5334/ijic.2916
- Hu TH, Su WW, Yang CC, et al. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan. Am J Kidney Dis. 2021;78:511–519.e1. DOI: 10.1053/j.ajkd.2021.03.017
- Littlelwood R, Walker J, Rogany A. Childhood obesity: overarching, statewide governance as a successful enabler to an integrated approach for prevention and management. Int J Integr Care. 2018;18:1–2. DOI: 10.5334/ijic.s1098
- Cronin J, Murphy A, Savage E. Can chronic disease be managed through integrated care cost-effectively? Evidence from a systematic review. Ir J Med Sci. 2017;186:827–834. DOI: 10.1007/s11845-017-1600-5
- Rohwer A, Nicol JU, Toews I, et al. Effects of integrated models of care for diabetes and hypertension in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open. 2021;11:
e043705 . DOI: 10.1136/bmjopen-2020-043705 - Desmedt M, Vertriest S, Hellings J, et al. Economic impact of integrated care models for patients with chronic diseases: a systematic review. Value Health. 2016;19:892–902. DOI: 10.1016/j.jval.2016.05.001
- McCombe G, Lim J, Van Hout MC, et al. Integrating Care for Diabetes and Hypertension with HIV Care in Sub-Saharan Africa: A Scoping Review. Int J Integr Care. 22. Epub ahead of print 2022. DOI: 10.5334/ijic.5839
- Njuguna B, Vorkoper S, Patel P, et al. Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps. AIDS. 2018;32:
S33 . DOI: 10.1097/QAD.0000000000001887 - Ameh S. Evaluation of an integrated HIV and hypertension management model in rural South Africa: a mixed methods approach. Glob Health Action. 2020;13:
1750216 . DOI: 10.1080/16549716.2020.1750216 - Watkins DA, Tulloch NL, Anderson ME, et al. Delivery of health care for cardiovascular and metabolic diseases among people living with HIV/AIDS in African countries: a systematic review protocol. Syst Rev. 2016;5:1–8. DOI: 10.1186/s13643-016-0241-5
- NICE. Guide to the Methods of Technology Appraisal. 2013 [Internet].
- Briggs ADM, Wolstenholme J, Blakely T, et al. Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions. Popul Health Metr. 2016;14:1–12. DOI: 10.1186/s12963-016-0085-1
- Breeze PR, Squires H, Ennis K, et al. Guidance on the use of complex systems models for economic evaluations of public health interventions. Health Econ.
- Marshall DA, Grazziotin LR, Regier DA, et al. Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling. Value Health. 2020;23:566–573. DOI: 10.1016/j.jval.2020.01.016
- Twumwaa TE, Justice N, Robert van DM, et al. Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review. BMC Health Serv Res. 2022;22:
1397 . DOI: 10.1186/s12913-022-08820-7 - Erku D, Mersha AG, Ali EE, et al. A systematic review of scope and quality of health economic evaluations conducted in Ethiopia. Health Policy Plan. 2022;37:514–522. DOI: 10.1093/heapol/czac005
- National Research Council. The continuing epidemiological transition in sub-Saharan Africa: a workshop summary. Washington D.C.; 2012.
- Miranda JJ, Kinra S, Casas JP, et al. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008;13:1225–1234. DOI: 10.1111/j.1365-3156.2008.02116.x
- Hosseinpoor AR, Bergen N, Kunst A, et al. Socioeconomic inequalities in risk factors for non communicable diseases in low-income and middle-income countries: results from the World Health Survey. BMC Public Health. 2012;12:
912 . DOI: 10.1186/1471-2458-12-912
DOI: https://doi.org/10.5334/ijic.9075 | Journal eISSN: 1568-4156
Language: English
Submitted on: Dec 6, 2024
Accepted on: Mar 26, 2026
Published on: Apr 27, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
© 2026 Elvis Omondi Achach Wambiya, Duncan Gillespie, Robert Akparibo, James Odhiambo Oguta, Catherine Akoth, Peter Otieno, Peter J. Dodd, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.